Motilin vs Trefoil factor 2

Head-to-head comparison of Motilin (Motilin) and Trefoil factor 2 (Trefoil factor 2 (Spasmolytic Polypeptide)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyMotilinTrefoil factor 2
CategoryGastrointestinalGastrointestinal
Full NameMotilinTrefoil factor 2 (Spasmolytic Polypeptide)
Molecular Weight~2.7 kDa≈11–12 kDa
Half-Life~20 minUnknown
Amino Acids22106
Typical DoseNo standard approved dose; experimental use onlynone established
RouteIV|SCoral/enteral|research-only
Purity≥98%≥98%
Studies Count8180
Research StatusEndogenousPre-clinical

Motilin Benefits

  • migrating motor complex support
  • gastric emptying
  • small-bowel clearance

Trefoil factor 2 Benefits

  • epithelial restitution
  • barrier protection
  • ulcer healing

Motilin Dosing

0.1–1 mg (experimental)|IV/SC

Trefoil factor 2 Dosing

No established clinical dose|preclinical only

Motilin Side Effects

  • cramping
  • nausea

Trefoil factor 2 Side Effects

  • limited human data
  • theoretical growth-factor concerns
  • GI discomfort

Research Overview

Motilin

Motilin is a 22-amino-acid peptide released from the upper small intestine and is one of the classic physiologic prokinetic signals. It is a real peptide target for GI motility research, though not commonly used as a standard drug.

Trefoil factor 2

TFF2 strengthens mucus-barrier repair and epithelial restitution after gastric injury in experimental systems, making it a well-known gastric-protective peptide.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

Motilin stacks with:

MLNmotilin

Trefoil factor 2 stacks with:

TFF2spasmolytic polypeptide
motilityprokineticgastric-emptyinggastrointestinalgastric-protectionmucosal-repair